AT
Actinogen Medical Limited
ATGGF · OTC
$0.04 +0.00% (+$0.00)
1M -12.50%
Market Cap $180.2M
P/E Ratio -
Div. Yield -
ROE 85.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 8.44x
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Book val. growth 16.77%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 85.31%
ROA 52.03%
Asset turnover 0.00x
Debt
69 /100
Low Current ratio 3.45x
Int. coverage -60.34x
Debt/Equity 0.22x
Stability
56 /100
Moderate Rev. volatility 105.05%
EPS volatility 11.80%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ATGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Nadcházející události
24 ÚNO
Earnings
Upcoming earnings report